Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways
Authors
Keywords
Salidroside, Pulmonary fibrosis, EMT, NF-κB p65 signaling pathway, Nrf2 signaling pathway, TGF-β1/Smad2/3 signaling pathway
Journal
CELL STRESS & CHAPERONES
Volume 21, Issue 2, Pages 239-249
Publisher
Springer Nature
Online
2015-11-17
DOI
10.1007/s12192-015-0654-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway
- (2015) Xiaoying Huang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions
- (2015) Veronica Della Latta et al. PHARMACOLOGICAL RESEARCH
- Salidroside inhibits oxygen glucose deprivation (OGD)/re-oxygenation-induced H9c2 cell necrosis through activating of Akt–Nrf2 signaling
- (2014) Koulong Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Nuclear factor-kappa-B signaling in lung development and disease: One pathway, numerous functions
- (2014) Cristina M. Alvira BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY
- Salidroside induces neuronal differentiation of mouse mesenchymal stem cells through Notch and BMP signaling pathways
- (2014) Hong-Bin Zhao et al. FOOD AND CHEMICAL TOXICOLOGY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Randomized Trial of Acetylcysteine in Idiopathic Pulmonary Fibrosis
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
- (2014) L Jiang et al. ONCOGENE
- Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis
- (2014) Narcy Arizmendi et al. RESPIRATORY RESEARCH
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Production of salidroside in metabolically engineered Escherichia coli
- (2014) Yanfen Bai et al. Scientific Reports
- Pathogenesis of Idiopathic Pulmonary Fibrosis
- (2013) Paul J. Wolters et al. Annual Review of Pathology-Mechanisms of Disease
- Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
- (2013) Ganesh Raghu et al. EUROPEAN RESPIRATORY JOURNAL
- Therapy for Fibrotic Diseases: Nearing the Starting Line
- (2013) S. L. Friedman et al. Science Translational Medicine
- A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
- (2012) Imre Noth et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The transcription factor NF-E2-related Factor 2 (Nrf2): a protooncogene?
- (2012) Phillip Shelton et al. FASEB JOURNAL
- Protective effects of salidroside fromRhodiola roseaon LPS-induced acute lung injury in mice
- (2012) Shuang Guan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- The mechanical memory of lung myofibroblasts
- (2012) Jenna L. Balestrini et al. Integrative Biology
- Pulmonary fibrosis: patterns and perpetrators
- (2012) Paul W. Noble et al. JOURNAL OF CLINICAL INVESTIGATION
- Protective Effects of a Rhodiola Crenulata Extract and Salidroside on Hippocampal Neurogenesis against Streptozotocin-Induced Neural Injury in the Rat
- (2012) Ze-qiang Qu et al. PLoS One
- Oxidative Stress and Antioxidant Defense
- (2012) Esra Birben et al. World Allergy Organization Journal
- Smad Signaling Is Required to Maintain Epigenetic Silencing during Breast Cancer Progression
- (2010) P. Papageorgis et al. CANCER RESEARCH
- Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis
- (2010) Marialuisa Bocchino et al. PLoS One
- Contribution of Epithelial-derived Fibroblasts to Bleomycin-induced Lung Fibrosis
- (2009) Harikrishna Tanjore et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Endothelial–Mesenchymal Transition in Bleomycin-Induced Pulmonary Fibrosis
- (2009) Naozumi Hashimoto et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Pretreatment with Rhodiola Rosea Extract Reduces Cognitive Impairment Induced by Intracerebroventricular Streptozotocin in Rats: Implication of Anti-oxidative and Neuroprotective Effects
- (2009) ZE-QIANG QU et al. BIOMEDICAL AND ENVIRONMENTAL SCIENCES
- Tissue stiffness, latent TGF-β1 Activation, and mechanical signal transduction: Implications for the pathogenesis and treatment of fibrosis
- (2009) Boris Hinz Current Rheumatology Reports
- Oxidative Stress and Antioxidants in the Pathogenesis of Pulmonary Fibrosis: A Potential Role for Nrf2
- (2007) Dianne M. Walters et al. ANTIOXIDANTS & REDOX SIGNALING
- Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine
- (2007) Kelly C. Teixeira et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now